Henning Willers, MD
Massachusetts General Hospital
Henning Willers, MD, is a clinician-scientist in the Department of Radiation Oncology at Massachusetts General Hospital (MGH) and an Associate Professor at Harvard Medical School.
Dr. Willers obtained his MD degree at the University of Hamburg, Germany, in 1994. Following a postdoctoral fellowship under Simon N. Powell, MD, PhD, and radiation oncology residency training at MGH, he joined the MGH faculty in 2005. In 2008, Dr. Willers established the Pulmonary SBRT Program at the MGH, and in 2016, he was named the Director of the Thoracic Radiation Oncology Program at MGH, succeeding Noah C. Choi, MD.
NCI-funded research in his laboratory focuses on molecular mechanisms of radiation resistance and the identification of targeted radiosensitizers and associated biomarkers. Another major interest is the targeting of DNA repair pathways in lung and other cancers with proton radiation and PARP inhibitors.
Dr. Willers has also led or co-led clinical trials on esophagus sparing with IMRT in locally advanced lung cancer, the integration of chemoradiation with EGFR inhibition in EGFR mutant non-metastatic lung cancer, the use of consolidation radiation therapy in metastatic oncogene-driven lung cancer, and the combination of PARP and EGFR inhibitors in metastatic EGFR mutant lung cancer.
Other current activities include service on the Governing Council of the Radiation Research Society, on the Editorial Board of Radiotherapy & Oncology, and on the ABR Radiation Biology Committee.
Follow him on Twitter: @henningwillers
Sunday, September 15
10:15 AM – 11:45 AM